neostigmine methylsulfate

Generic: neostigmine methylsulfate

Labeler: xiromed llc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name neostigmine methylsulfate
Generic Name neostigmine methylsulfate
Labeler xiromed llc
Dosage Form INJECTION
Routes
INTRAVENOUS
Active Ingredients

neostigmine methylsulfate 1 mg/mL

Manufacturer
Xiromed LLC

Identifiers & Regulatory

Product NDC 70700-172
Product ID 70700-172_8649cf31-5ecf-2048-5bf0-1b6e84f190f4
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA212968
Listing Expiration 2026-12-31
Marketing Start 2020-09-09

Pharmacologic Class

Classes
cholinesterase inhibitor [epc] cholinesterase inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 70700172
Hyphenated Format 70700-172

Supplemental Identifiers

RxCUI
311935 311936
UPC
0370700172223
UNII
98IMH7M386

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name neostigmine methylsulfate (source: ndc)
Generic Name neostigmine methylsulfate (source: ndc)
Application Number ANDA212968 (source: ndc)
Routes
INTRAVENOUS
source: ndc

Resolved Composition

Strengths
  • 1 mg/mL
source: ndc
Packaging
  • 1 VIAL, MULTI-DOSE in 1 CARTON (70700-172-22) / 10 mL in 1 VIAL, MULTI-DOSE
  • 10 VIAL, MULTI-DOSE in 1 CARTON (70700-172-23) / 10 mL in 1 VIAL, MULTI-DOSE
source: ndc

Packages (2)

Ingredients (1)

neostigmine methylsulfate (1 mg/mL)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "8649cf31-5ecf-2048-5bf0-1b6e84f190f4", "openfda": {"upc": ["0370700172223"], "unii": ["98IMH7M386"], "rxcui": ["311935", "311936"], "spl_set_id": ["801225d9-eb71-dbef-e860-4caf7a22f27f"], "manufacturer_name": ["Xiromed LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, MULTI-DOSE in 1 CARTON (70700-172-22)  / 10 mL in 1 VIAL, MULTI-DOSE", "package_ndc": "70700-172-22", "marketing_start_date": "20200909"}, {"sample": false, "description": "10 VIAL, MULTI-DOSE in 1 CARTON (70700-172-23)  / 10 mL in 1 VIAL, MULTI-DOSE", "package_ndc": "70700-172-23", "marketing_start_date": "20200909"}], "brand_name": "Neostigmine methylsulfate", "product_id": "70700-172_8649cf31-5ecf-2048-5bf0-1b6e84f190f4", "dosage_form": "INJECTION", "pharm_class": ["Cholinesterase Inhibitor [EPC]", "Cholinesterase Inhibitors [MoA]"], "product_ndc": "70700-172", "generic_name": "Neostigmine methylsulfate", "labeler_name": "Xiromed LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Neostigmine methylsulfate", "active_ingredients": [{"name": "NEOSTIGMINE METHYLSULFATE", "strength": "1 mg/mL"}], "application_number": "ANDA212968", "marketing_category": "ANDA", "marketing_start_date": "20200909", "listing_expiration_date": "20261231"}